NMRA- Neumora Therapeutics, Inc.

Name: Neumora Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neumora Therapeutics, Inc. (NMRA) has 12 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. NMRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Arch Venture Partners X, LLC	6.05M	$10.98M	-
10%	Burow Kristina	6.05M	$10.98M	-
10%	Arch Venture Partners Xii, LLC	6.05M	$10.98M	-
Other	Berns Paul L	1.65M	$2.99M	-
Pres	Pinto Joshua	1.20M	$2.18M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 11, 2025	Aurora Daljit Singh	See Remarks	Sell	114,703	$2.68	$307,025.52	-100%	-13.1%	-
Oct 27, 2025	Burow Kristina68	Director, 10% Owner	Buy	1,915,700	$2.61	$4,999,977.00	+46.4%	-24.2%	-
Oct 27, 2025	Arch Venture Partners X, LLC	10% Owner	Buy	1,915,700	$2.61	$4,999,977.00	+46.4%	-24.2%	-
Oct 27, 2025	Arch Venture Partners Xii, LLC63	10% Owner	Buy	1,915,700	$2.61	$4,999,977.00	+46.4%	-24.2%	-
Feb 18, 2025	Berns Paul L	See Remarks	Sell	13,871	$1.69	$23,468.34	-0.2%	-60.1%	+107.5%
Feb 18, 2025	Milligan Michael Lee	See Remarks	Sell	1,978	$1.69	$3,350.53	-8.1%	-60.1%	+107.5%
Feb 18, 2025	Aurora Daljit Singh	Chief Strategy Officer	Sell	8,565	$1.68	$14,347.23	-8.8%	-60.1%	+107.5%
Feb 18, 2025	Lenz Robert A.80	Head Of R&D	Sell	5,614	$1.67	$9,383.24	-1.8%	-60.1%	+107.5%
Feb 18, 2025	Pinto Joshua74	President	Sell	8,048	$1.67	$13,477.18	-9.5%	-60.1%	+107.5%
Oct 18, 2024	Fust Matthew K77	Director	Sale+OE	21,788	$17.03	$370,961.81	-35.1%	-86.8%	-89.5%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC